Sort
23,748 grants matching “melanoma”
LuIII parvovirus targets glioma
$345,488Anthony N Van Den Pol · Yale University · R01 · FY2015 · CA
Telomere-Mediated Protective Responses in Skin
$345,477Barbara A Gilchrest · Boston University Medical Campus · R01 · FY2007 · CA
Mass Spectrometry of Modified RNAs
$345,462Patrick A Limbach · University Of Cincinnati · R01 · FY2025 · GM
Separating autoimmunity and anti-tumor immunity
$345,413Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2016 · CA
Separating autoimmunity and anti-tumor immunity
$345,413Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2015 · CA
Project 1: Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$345,406David E Fisher · Massachusetts General Hospital · P01 · FY2019 · CA
Administrative Core
$345,373Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Drug Development of Ribonucleotide Reductase Inhibitor
$345,315Yun Yen · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Lymphatic Imaging
$345,293Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Improvement of cellular immunotherapy during dysbiosis- Resubmission
$345,287Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2021 · CA
Clinical Trail of Vaccine in Combination with Toll-Like Receptor (TLR)
$345,281Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$345,281Ann Richmond · Vanderbilt University · R01 · FY2024 · CA
Optimizing systemic immunotherapy for personalized brain metastasis treatment
$345,270Michael Lim · Stanford University · U54 · FY2024 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$345,260Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2022 · CA
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
$345,257Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2017 · CA
Northern New Jersey Community Clinical Oncology Program
$345,238Hackensack University Medical Center · U10 · FY2003 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$345,230Ahmed Chadli · Augusta University · R01 · FY2023 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$345,230Ahmed Chadli · Augusta University · R01 · FY2022 · CA
LuIII parvovirus targets glioma
$345,229Anthony N Van Den Pol · Yale University · R01 · FY2013 · CA
Targeting a Treg deubiquitinase in antitumor immune therapy
$345,141Deyu Fang · Northwestern University At Chicago · R01 · FY2022 · CA
Chemiexcitation: A New Mode of Skin Disease
$345,110Douglas E Brash · Yale University · R01 · FY2020 · AR
MELANOMA CONTROL FOR SIBLING OF MELANOMA PATIENTS
$345,094Boston University Medical Campus · R01 · FY2001 · CA
Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts
$345,034Yinsheng Wang · University Of California Riverside · R01 · FY2019 · CA
Modulation of inflammasome-mediated cytokine activation by EGCG in human melanoma.
$345,034Mayumi Fujita · University Of Colorado Denver · R01 · FY2019 · CA
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$345,003Yuhang Zhang · University Of Cincinnati · R01 · FY2024 · CA